Jean Bennett, M.D., Ph.D., joins REGENXBIO Board of Directors
She will serve as a member of REGENXBIO's Nominating and Corporate Governance Committee.
Inspired by the late Tachi Yamada, Jim Wilson launches new nonprofit targeting underserved ultra-rare diseases
A group of powerhouse biotech leaders is coming together to launch a new nonprofit, one aimed at delivering therapies to rare disease populations they believe pharma is leaving behind.
BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma
A BioNTech-led team designed a cocktail of mRNAs that instruct cells to produce four cancer-fighting molecules.
iECURE emerges with $50M to search for ‘holy grail’ and ‘untapped frontier’ of gene editing
The biotech will use the funds for a slate of gene insertion programs for liver disorders out of the lab of gene therapy pioneer Jim Wilson, M.D., Ph.D. at Penn.
Penn scientists win $3 million Breakthrough Prize for RNA research that enabled COVID-19 vaccines
Sixteen years after their research at Penn paved the way for billions to be vaccinated against COVID-19, two scientists from Penn have been honored with the Breakthrough Prize.
One of Tachi’s newly born legacy biotechs raises $135M and enlists an A-list board to advance late-stage vaccine
Tachi Yamada's biotechs are continuing to make news.
Penn Medicine and Wharton Social Impact Initiative Launch New $5 Million Investment Initiative for Businesses that Improve Health of Philadelphians
Three start-up companies will be the first to receive investment from the Fund for Health, a joint partnership between Penn Medicine and the Wharton Social Impact Initiative.
Penn mRNA researchers Drew Weissman and Katalin Karikó awarded the 2021 Albany Prize
The award, one of the largest in medicine and science in the U.S., has been given for the last 20 years by Albany Medical Center to those who have altered and positively impacted the course
COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval
The U.S. FDA has given the first full approval to a COVID-19 mRNA vaccine, which uses modified mRNA technology invented and developed by scientists at Penn.
Engineers create faster and cheaper COVID-19 testing with pencil lead
To address cost, time and accuracy, a new electrochemical test developed by Penn researchers uses electrodes made from graphite—the same material found in pencil lead.